While in humans, ZIKV inhibits type I IFN signaling by proteasome-mediated degradation of STAT2, it cannot antagonize murine IFN-α/β signaling or effector functions, and wild type adult mice are generally resistant to ZIKV and do not develop the typical clinical manifestations of ZIKV infection [51]. Here, STAT2 is linked to Zika virus infectious disease.